【浙江医药(600216.SH)】VA价格下跌Q2业绩承压下滑,下半年维生素供需有望好转——2022年半年报点评(赵乃迪)

市场资讯
27 Aug 2022

事件:公司发布2022年半年度报告,2022年上半年公司实现营业收入41亿元,同比下降10.8%;归母净利润3.9亿元,同比下降23%;扣非后归母净利润3.8亿元,同比下降18%。其中Q2单季度公司实现营收19.3亿元,同比下降12.8%,环比下降11.5%;实现归母净利润1.3亿元,同比下降46%,环比下降50%。点评:主营产品VA价格下跌,Q2业绩同比下滑22年上半年国内VA、VE均价分别为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10